SLC2A5 and malignant colon neoplasm: A recent study showed that a histone deacetylase inhibitor, trichostatin A, which induces SNAI1 and SNAI2 expression, inhibits SLC2A5/GLUT5 expression and thereby sensitizes colon cancer cells to cisplatin and oxaliplatin [83].